The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria

Gynecologic Oncology

Volumn 117, Issue 1, 2010, Pages 96-102

  Villavicencio, A ^a   Aguilar, G ^b   Arguello G ^a   Dunner C ^a   Gabler, F ^c   Soto, E ^c   Gaete, F ^c   Penaloza P ^c   Celis, M ^c   Rojas, C ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

AKT; Endometrial cancer; ERK1,2; Obesity; Proliferation

Indexed keywords

ESTROGEN; HISTONE H3; INSULIN; KI 67 ANTIGEN; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; STEROID;

ADULT; ARTICLE; BODY MASS; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; OBESITY; PRIORITY JOURNAL; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CELL GROWTH PROCESSES; ENDOMETRIUM; ENZYME ACTIVATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OBESITY; ONCOGENE PROTEIN V-AKT; OVERWEIGHT;

EID: 77949335473     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.12.022     Document Type: Article

References (62)

1. McRae M.A., Blasco L., and Lyttle C.R. Serum hormones and their receptors in women with normal and inadequate corpus luteum function. Fertil. Steril. 42 (1984) 58-63
2. Shiozawa T., Miyamoto T., Kashima H., Nakayama K., Nikaido T., and Konishi I. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 23 (2004) 8603-8610
3. Dimitriadis E., White C.A., Jones R.L., and Salamonsen L.A. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum. Reprod. Update 11 (2005) 613-630
4. Fukuda J., Nasu K., Sun B., Shang S., Kawano Y., and Miyakawa I. Effects of leptin on the production of cytokines by cultured human endometrial stromal and epithelial cells. Fertil. Steril. 80 (2003) 783-787
5. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 27 (2006) 762-778
6. Kaaks R., Lukanova A., and Kurzer M.S. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1531-1543
7. Purdie D.M., and Green A.C. Epidemiology of endometrial cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 15 (2001) 341-354
8. Ryan A.J., Susil B., Jobling T.W., and Oehler M.K. Endometrial. cancer. Cell Tissue Res. 322 (2005) 53-61
9. Gangemi M., Meneghetti G., Predebon O., Scappatura R., and Rocco A. Obesity as a risk factor for endometrial cancer. Clin. Exp. Obstet. Gynecol. 14 (1987) 119-122
10. Xu W., Dai Q., Ruan Z., Cheng J., Jin F., and Shu X. Obesity at different ages and endometrial cancer risk factors in urban Shanghai, China. Zhonghua Liu Xing Bing Xue Za Zhi 23 (2002) 347-351
11. Akhmedkhanov A., Zeleniuch-Jacquotte A., and Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann. N. Y. Acad. Sci. 943 (2001) 296-315
12. Austin H., Austin J.M., Partridge E.E., Hatch K.D., and Shingleton H.M. Endometrial cancer, obesity, and body fat distribution. Cancer Res. 51 (1991) 568-572
13. Olson S.H., Trevisan M., Marshall J.R., Graham S., Zielezny M., Vena J.E., et al. Body mass index, weight gain, and risk of endometrial cancer. Nutr. Cancer 23 (1995) 141-149
14. Bianchini F., Kaaks R., and Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 3 (2002) 565-574
15. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003) 1625-1638
16. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347 (2002) 1593-1603
17. Lax S.F. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium. Pathology 39 (2007) 46-54
18. Matias-Guiu X., Catasus L., Bussaglia E., Lagarda H., Garcia A., Pons C., et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum. Pathol. 32 (2001) 569-577
19. Burgering B.M., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599-602
20. Alessi D.R., and Cohen P. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8 (1998) 55-62
21. Negoro S., Oh H., Tone E., Kunisada K., Fujio Y., Walsh K., et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 103 (2001) 555-561
22. Ivanova T., Mendez P., Garcia-Segura L.M., and Beyer C. Rapid stimulation of the PI3-kinase/Akt signalling pathway in developing midbrain neurones by oestrogen. J. Neuroendocrinol. 14 (2002) 73-79
23. Schubbert S., Shannon K., and Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7 (2007) 295-308
24. Guzeloglu Kayisli O., Kayisli U.A., Luleci G., and Arici A. In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biol. Reprod. 71 (2004) 714-721
25. Gentilini D., Busacca M., Di Francesco S., Vignali M., Viganò P., and Di Blasio A.M. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol. Hum. Reprod. 13 (2007) 317-322
26. Guo R.X., Wei L.H., Tu Z., Sun P.M., Wang J.L., Zhao D., et al. 17β-Estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J. Steroid. Biochem. Mol. Biol. 99 (2006) 9-18
27. Zhang L.L., Li X.P., Wang J.L., and Wei L.H. Membrane-initiated nongenomic effect on mitogen-activated protein kinase signal transduction of estrogen in endometrial carcinoma cell. Zhonghua Fu Chan Ke Za Zhi 43 (2008) 615-618
28. Sharma D., Saxena N.K., Vertino P.M., and Anania F.A. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocr. Relat. Cancer 13 (2006) 629-640
29. Lathi R.B., Hess A.P., Tulac S., Nayak N.R., Conti M., and Giudice L.C. Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways. J. Clin. Endocrinol. Metab. 90 (2005) 1599-1606
30. Horrée N., van Diest P.J., van der Groep P., Sie-Go D.M., and Heintz A.P. Progressive derailment of cell cycle regulators in endometrial carcinogenesis. J. Clin. Pathol. 6 (2008) 36-42
31. Magdelénat H. Tumour markers in oncology: past, present and future. J. Immunol. Methods 150 (1992) 133-143
32. Brenner R.M., Slayden O.D., Rodgers W.H., Critchley H.O., Carroll R., Nie X.J., et al. Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometrium. Hum. Reprod. 18 (2003) 1185-1193
33. Noyes R.W., Hertig D.T., and Rock J. Dating the endometrial biopsy. Fertil. Steril. 1 (1950) 3-25
34. Burton B.T., Foster W.R., Hirsch J., and Van I. TB Health implications of obesity: an NIH Consensus Development Conference. Int. J. Obes. 9 (1985) 155-170
35. Pan Q., and Chegini N. MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin. Reprod. Med. 26 (2008) 479-493
36. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4 (2004) 579-591
37. Scholzen T., and Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 182 (2000) 311-322
38. Brown D.C., and Gatter K.C. Ki67 protein: the immaculate deception?. Histopathology 40 (2002) 2-11
39. Jürgensen A., Mettler L., Volkov N.I., and Parwaresch R. Proliferative activity of the endometrium throughout the menstrual cycle in infertile women with and without endometriosis. Fertil. Steril. 66 (1996) 369-375
40. Hall P.A., and Levison D.A. Review: assessment of cell proliferation in histological material. J. Clin. Pathol. 43 (1990) 184-192
41. Foster J.S., Henley D.C., Ahamed S., and Wimalasena J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab. 12 (2001) 320-327
42. Prall O.W., Rogan E.M., Musgrove E.A., Watts C.K., and Sutherland R.L. c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol. Cell Biol. 18 (1998) 4499-4508
43. Mertens H.J., Heineman M.J., and Evers J.L. The expression of apoptosis-related proteins Bcl-2 and Ki67 in endometrium of ovulatory menstrual cycles. Gynecol. Obstet. Invest 53 (2002) 224-230
44. Vaskivuo T.E., Stenback F., and Tapanainen J.S. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Cancer 95 (2002) 1463-1471
45. Key T.J., Allen N.E., Verkasalo P.K., and Banks E. Energy balance and cancer: the role of sex hormones. Proc. Nutr. Soc. 60 (2001) 81-89
46. Gao Q., Ye F., Xia X., Xing H., Lu Y., Zhou J., et al. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma. J. Huazhong Univ. Sci. Technolog. Med. Sci. 29 (2009) 59-63
47. Terakawa N., Kanamori Y., and Yoshida S. Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer. Endocr. Relat. Cancer 10 (2003) 203-208
48. Kanamori Y., Kigawa J., Itamochi H., Shimada M., Takahashi M., Kamazawa S., et al. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clin. Cancer Res. 7 (2001) 892-895
49. Franke T., Kaplan D., and Cantley L. PI3K: downstream AKTion blocks apoptosis. Cell 88 (1997) 435-437
50. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., and Stanbridge E. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
51. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., and Hu L.S. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
52. González R.R., Caballero-Campo P., Jasper M., Mercader A., Devoto L., Pellicer A., et al. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J. Clin. Endocrinol. Metab. 85 (2000) 4883-4888
53. Alfer J., Müller-Schöttle F., Classen-Linke I., von Rango U., Happel L., Beier-Hellwig K., et al. The endometrium as a novel target for leptin: differences in fertility and subfertility. Mol. Hum. Reprod. 6 (2000) 595-601
54. Kitawaki J., Koshiba H., Ishihara H., Kusuki I., Tsukamoto K., and Honjo H. Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle. J. Clin. Endocrinol. Metab. 85 (2000) 1946-1950
55. Nagamani M., Stuart C.A., Dunhardt P.A., and Doherty M.G. Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer. Am. J. Obstet. Gynecol. 165 (1991) 1865-1871
56. Strowitzki T., von Eye H.C., Kellerer M., and Häring H.U. Tyrosine kinase activity of insulin-like growth factor I and insulin receptors in human endometrium during the menstrual cycle: cyclic variation of insulin receptor expression. Fertil. Steril. 59 (1993) 315-322
57. Ganeff C., Chatel G., Munaut C., Frankenne F., Foidart J.M., and Winkler R. The IGF system in in-vitro human decidualization. Mol. Hum. Reprod. 15 (2009) 27-38
58. Tchernof A., and Després J.P. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm. Metab. Res. 32 (2000) 526-536
59. Pugeat M., Crave J.C., Elmidani M., Nicolas M.H., Garoscio-Cholet M., and Lejeune H. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J. Steroid. Biochem. Mol. Biol. 40 (1991) 841-849
60. Kokkoris P., and Pi-Sunyer F.X. Obesity and endocrine disease. Endocrinol. Metab. Clin. North Am. 32 (2003) 895-914
61. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., and Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 (2000) 538-541
62. Morán C., García-Hernández E., Cortés M.A., Salazar L., and Bermúdez J.A. Estradiol and progesterone endometrial receptors and body fat distribution in obese women. Gynecol. Obstet. Invest 42 (1996) 117-119